Intracellular signalling pathways regulating the adaptation of skeletal muscle to exercise and nutritional changes

Histology and Histopathology

Volumn 24, Issue 2, 2009, Pages 209-222

  Matsakas, Antonios ^a   Patel, Ketan ^a  

^a UNIVERSITY OF READING   (United Kingdom)

Author keywords

Exercise; MTOR; Myostatin; Nutrition; Protein synthesis

Indexed keywords

ADENYLATE KINASE; MAMMALIAN TARGET OF RAPAMYCIN; MUSCLE PROTEIN; MYOSTATIN; PROTEIN KINASE;

AMINO TERMINAL SEQUENCE; AUTOPHOSPHORYLATION; CARBOHYDRATE INTAKE; CELL ENERGY; CELL GROWTH; CELL METABOLISM; CELL PROLIFERATION; DIET SUPPLEMENTATION; ENERGY CONSUMPTION; ENERGY METABOLISM; ENZYME ACTIVATION; GROWTH INHIBITION; GROWTH REGULATION; HOMEOSTASIS; HUMAN; MOLECULAR BIOLOGY; MUSCLE ATROPHY; MUSCLE CONTRACTION; MUSCLE EXCITATION; MUSCLE EXERCISE; MUSCLE GROWTH; MUSCLE HYPERTROPHY; MUSCLE MASS; MUSCLE METABOLISM; MUSCLE STRENGTH; NONHUMAN; NUTRITION; PROTEIN DEGRADATION; PROTEIN DEPHOSPHORYLATION; PROTEIN DOMAIN; PROTEIN INTAKE; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS INHIBITION; PROTEIN TARGETING; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; UPREGULATION; ANIMAL; BIOLOGICAL MODEL; CYTOPLASM; EXERCISE; METABOLISM; NUTRITIONAL SCIENCE; PHENOTYPE;

ADENYLATE KINASE; ANIMALS; CYTOPLASM; EXERCISE; HUMANS; MODELS, BIOLOGICAL; MUSCLE PROTEINS; MUSCLE, SKELETAL; MYOSTATIN; NUTRITIONAL SCIENCES; PHENOTYPE; PROTEIN KINASES; SIGNAL TRANSDUCTION;

EID: 59149089225     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. Adams G.R. (2002). Invited Review: Autocrine/paracrine IGF-I and skeletal muscle adaptation. J. Appl. Physiol. 93, 1159-1167.
2. Adams G.R. and Haddad F. (1996). The relationships among IGF-1, DNA content, and protein accumulation during skeletal muscle hypertrophy. J. Appl. Physiol. 81, 2509-2516.
3. Anthony J.C., Lang C.H., Crozier S.J., Anthony T.G., MacLean D.A., Kimball S.R. and Jefferson L.S. (2002). Contribution of insulin to the translational control of protein synthesis in skeletal muscle by leucine. Am. J. Physiol. 282, E1092-E1101.
4. Anthony T.G., McDaniel B.J., Knoll P., Bunpo P., Paul G.L. and McNurlan M.A. (2007). Feeding meals containing soy or whey protein after exercise stimulates protein synthesis and translation initiation in the skeletal muscle of male rats. J. Nutr. 137, 357-362.
5. Atherton P.J., Babraj J., Smith K., Singh J., Rennie M.J. and Wackerhage H. (2005). Selective activation of AMPK-PGC-1alpha or PKB-TSC2-mTOR signaling can explain specific adaptive responses to endurance or resistance training-like electrical muscle stimulation. FASEB J. 19, 786-788.
6. Baar K. (2006). Training for endurance and strength: Lessons from cell signaling. Med. Sci. Sports Exerc. 38, 1939-1944.
7. Baar K., Nader G. and Bodine S. (2006). Resistance exercise, muscle loading/unloading and the control of muscle mass. Essays. Biochem. 42, 61-74.
8. Backer J.M. (2008). The regulation and function of Class III PI3Ks: novel roles for Vps34. Biochem. J. 410, 1-17.
9. Blomstrand E., Eliasson J., Karlsson H.K. and Köhnke R. (2006). Branched-chain amino acids activate key enzymes in protein synthesis after physical exercise. J. Nutr. 136, 269S-273S.
10. Bodine S.C., Stitt T.N., Gonzalez M., Kline W.O., Stover G.L., Bauerlein R., Zlotchenko E., Scrimgeour A, Lawrence J.C., Glass D.J. and Yancopoulos G.D. (2001). Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat. Cell. Biol. 3, 1014-1049.
11. Browne G.J. and Proud C.G. (2002). Regulation of peptide-chain elongation in mammalian cells. Eur. J. Biochem. 269, 5360-5368.
12. Byfield M.P., Murray J.T. and Backer J.M. (2005). hVps34 is a nutrient-regulated lipid kinase required for activation of p70 S6 kinase. J. Biol. Chem. 280,33076-33082.
13. Cheng S.W., Fryer L.G., Carling D. and Shepherd P.R. (2004). Thr2446 is a novel mammalian target of rapamycin (mTOR) phosphorylation site regulated by nutrient status. J. Biol. Chem. 279, 15719-15722.
14. Coffey V.G., Zhong Z., Shield A., Canny B.J., Chibalin A.V., Zierath J.R. and Hawley J.A. (2006). Early signaling responses to divergent exercise stimuli in skeletal muscle from well-trained humans. FASEB J. 20, 190-192.
15. Cunningham J.T., Rodgers J.T., Arlow D.H., Vazquez F., Mootha V.K. and Puigserver P. (2007). mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex. Nature 450, 736-740.
16. Cuthbertson D., Smith K., Babraj J., Leese G., Waddell T., Atherton P., Wackerhage H., Taylor P.M. and Rennie M.J. (2005). Anabolic signaling deficits underlie amino acid resistance of wasting, aging muscle. FASEB J. 19, 422-424.
17. Cuthbertson D.J., Babraj J., Smith K., Wilkes E., Fedele M.J., Esser K. and Rennie M. (2006). Anabolic signaling and protein synthesis in human skeletal muscle after dynamic shortening or lengthening exercise. Am. J. Physiol. 290, E731-E738.
18. Deldicque L., Atherton P., Patel R., Theisen D., Nielens H., Rennie M.J. and Francaux M. (2008). Effects of resistance exercise with and without creatine supplementation on gene expression and cell signaling in human skeletal muscle. J. Appl. Physiol. 104, 371-378.
19. Dreyer H.C., Fujita S., Cadenas J.G., Chinkes D.L., Volpi E. and Rasmussen B.B. (2006). Resistance exercise increases AMPK activity and reduces 4E-BP1 phosphorylation and protein synthesis in human skeletal muscle. J. Physiol. 576, 613-624.
20. Dreyer H.C., Drummond M.J., Pennings B., Fujita S., Glynn E.L., Chinkes D.L., Dhanani S., Volpi E. and Rasmussen B.B. (2008). Leucine-enriched essential amino acid and carbohydrate ingestion following resistance exercise enhances mTOR signaling and protein synthesis in human muscle. Am. J. Physiol. 294, E392-E400.
21. Eliasson J., Elfegoun T., Nilsson J., Köhnke R., Ekblom B. and Blomstrand E. (2006). Maximal lengthening contractions increase p70 S6 kinase phosphorylation in human skeletal muscle in the absence of nutritional supply. Am. J. Physiol. 291, E1197-E1205.
22. Fitts R.H., Romatowski J.G., Peters J.R., Paddon-Jones D., Wolfe R.R. and Ferrando A.A. (2007). The deleterious effects of bed rest on human skeletal muscle fibers are exacerbated by hypercortisolemia and ameliorated by dietary supplementation. Am. J. Physiol. 293, C313-C320.
23. Fujita S., Dreyer H.C., Drummond M.J., Glynn E.L., Cadenas J.G., Yoshizawa F., Volpi E. and Rasmussen B.B. (2007). Nutrient signalling in the regulation of human muscle protein synthesis. J. Physiol. 582, 813-823.
24. Glass D.J. (2005). Skeletal muscle hypertrophy and atrophy signaling pathways. Int. J. Biochem. Cell Biol. 37, 1974-1984.
25. Haddad F. and Adams G.R. (2002). Selected contribution: acute cellular and molecular responses to resistance exercise. J. Appl. Physiol. 93, 394-403.
26. Hardie D.G. and Sakamoto K. (2006). AMPK: A key sensor of fuel and energy status in skeletal muscle. Physiology 21, 48-60.
27. Hay N. and Sonenberg N. (2004). Upstream and downstream of mTOR. Genes Dev. 18, 1926-1945.
28. Hickson R.C. (1980). Interference of strength development by simultaneously training for strength and endurance. Eur. J. Appl. Physiol. Occup. Physiol. 45, 255-263.
29. Horman S., Browne G., Krause U., Patel J., Vertommen D., Bertrand L., Lavoinne A., Hue L., Proud C. and Rider M. (2002). Activation of AMP-activated protein kinase leads to the phosphorylation of elongation factor 2 and an inhibition of protein synthesis. Curr. Biol. 12, 1419-1423.
30. Hornberger T.A. and Chien S. (2006). Mechanical stimuli and nutrients regulate rapamycin-sensitive signaling through distinct mechanisms in skeletal muscle. J. Cell. Biochem. 97, 1207-1216.
31. Hornberger T.A., Sukhija K.B. and Chien S. (2006). Regulation of mTOR by mechanically induced signaling events in skeletal muscle. Cell Cycle 5, 1391-1396.
32. Inoki K., Zhu T. and Guan K.L. (2003). TSC2 mediates cellular energy response to control cell growth and survival. Cell 115, 577-590.
33. Ivy J.L., Ding Z., Hwang H., Cialdella-Kam L.C. and Morrison P.J. (2008). Post exercise carbohydrate-protein supplementation: phosphorylation of muscle proteins involved in glycogen synthesis and protein translation. Amino. Acids. 35, 89-97.
34. Karlsson H.K., Nilsson P.A., Nilsson J., Chibalin A.V., Zierath J.R. and Blomstrand E. (2004). Branched-chain amino acids increase p70S6k phosphorylation in human skeletal muscle after resistance exercise. Am. J. Physiol. 287, E1-E7.
35. Kimball S.R. and Jefferson L.S. (2004). Amino acids as regulators of gene expression. Nutr. Metab. 1, 3.
36. Kimura N., Tokunaga C., Dalal S., Richardson C., Yoshino K., Hara K., Kemp B.E., Witters L.A., Mimura O. and Yonezawa K. (2003). A possible linkage between AMP-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) signalling pathway. Genes Cells 8, 65-79.
37. Koopman R., Pennings B., Zorenc A.H. and van Loon L.J. (2007). Protein ingestion further augments S6K1 phosphorylation in skeletal muscle following resistance type exercise in males. J. Nutr. 137, 1880-1886.
38. Kubica N., Bolster D.R., Farrell P.A., Kimball S.R. and Jefferson L.S. (2005). Resistance exercise increases muscle protein synthesis and translation of eukaryotic initiation factor 2Bepsilon mRNA in a mammalian target of rapamycin-dependent manner. J. Biol. Chem. 280, 7570-7580.
39. Mackenzie M.G., Hamilton D.L., Murray J.T. and Baar K. (2007). mVps34 is activated by an acute bout of resistance exercise. Biochem. Soc. Trans. 35, 1314-1316.
40. Mascher H., Andersson H., Nilsson P.A., Ekblom B. and Blomstrand E. (2007). Changes in signalling pathways regulating protein synthesis in human muscle in the recovery period after endurance exercise. Acta. Physiol. 191, 67-75.
41. Matsakas A and Diel P. (2005). The growth factor myostatin, a key regulator in skeletal muscle growth and homeostasis. Int. J. Sports Med. 26, 83-89.
42. McCarthy J.P., Agre J.C., Graf B.K., Pozniak M.A. and Vailas A.C. (1995). Compatibility of adaptive responses with combining strength and endurance training. Med. Sci. Sports Exerc. 27, 429-436.
43. Nader G.A. (2006). Concurrent strength and endurance training: From molecules to man. Med. Sci. Sports Exerc. 38, 1965-1970.
44. Nader G.A. and Esser K.A. (2001). Intracellular signaling specificity in skeletal muscle in response to different modes of exercise. J. Appl. Physiol. 90, 1936-1942.
45. Nelson A.G., Arnall D.A., Loy S.F., Silvester L.J. and Conlee R.K. (1990). Consequences of combining strength and endurance training regimens. Phys. Ther. 70, 287-294.
46. Newsholme E.A. and Blomstrand E. (2006). Branched-chain amino acids and central fatigue. J. Nutr. 136, 274S-276S.
47. Nobukuni T., Joaquin M., Roccio M., Dann S.G., Kim S.Y., Gulati P., Byfield M.P., Backer J.M., Natt F., Bos J.L., Zwartkruis F.J. and Thomas G. (2005). Amino acids mediate mTOR/raptor signaling through activation of class 3phosphatidylinositol 3OH-kinase. Proc. Natl. Acad. Sci. USA 102, 14238-14243.
48. Parkington J.D., Siebert A.P., LeBrasseur N.K. and Fielding R.A. (2003). Differential activation of mTOR singaling by contractile activity in skeletal muscle. Am. J. Physiol. 285, R1086-R1090.
49. Patel K., Macharia R. and Amthor H. (2005). Molecular mechanisms involving IGF-1 and myostatin to induce muscle hypertrophy as a therapeutic strategy for Duchenne muscular dystrophy. Acta Myol. 24, 230-241.
50. Phillips S.M., Tipton K.D., Aarsland A., Wolf S.E. and Wolfe R.R. (1997). Mixed muscle protein synthesis and breakdown after resistance exercise in humans. Am. J. Physiol. 273, E99-E107.
51. Quinn L.S., Anderson B.G. and Plymate S.R. (2007). Muscle-specific overexpression of the type 1 IGF receptor results in myoblast-independent muscle hypertrophy via PI3K, and not calcineurin, signaling. Am. J. Physiol. 293, E1538-E1551.
52. Rennie M.J. (2007). Exercise- and nutrient-controlled mechanisms involved in maintainance of the muscluloskeletal mass. Biochem. Soc. Trans. 35, 1302-1305.
53. Rennie M.J., Wackerhage H., Spangenburg E.E. and Booth F.W. (2004). Control of the size of the human muscle mass. Annu. Rev. Physiol. 66, 799-828.
54. Rennie M.J., Bohé J., Smith K., Wackerhage H. and Greenhaff P. (2006). Branched-chain amino acids as fuels and anabolic signals in human muscle. J. Nutr. 136, 264S-268S.
55. Sarbassov D.D., Guertin D.A., Ali S.M. and Sabatini D.M. (2005). Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307, 1098-1101.
56. Somanath P.R., Razorenova O.V., Chen J. and Byzova T.V. (2006). Akt1 in endothelial cell and angiogenesis. Cell Cycle 5, 512-518.
57. Song G., Ouyang G. and Bao S. (2005). The activation of Akt/PKB signaling pathway and cell survival. J. Cell. Mol. Med. 9, 59-71.
58. Spangenburg E.E., Le Roith D., Ward C.W. and Bodine S.C. (2008). A functional insulin-like growth factor receptor is not necessary for load-induced skeletal muscle hypertrophy. J. Physiol. 586, 283-291.
59. Stewart C.E. and Rittweger J. (2006). Adaptive processes in skeletal muscle: molecular regulators and genetic influences. J. Musculoskelet. Neuronal Interact. 6, 73-86.
60. Thomson D.M., Fick C.A. and Gordon S.E. (2008). AMPK activation attenuates S6K1, 4E-BP1, and eEF2 signaling responses to highfrequency electrically stimulated skeletal muscle contractions. J. Appl. Physiol. 104, 625-632.
61. Vary T.C. and Lynch C.J. (2007). Nutrient signaling components controlling protein synthesis in striated muscle. J. Nutr. 137, 1835-1843. Wang X. and Proud C.G. (2006). The mTOR pathway in the control of protein synthesis. Physiology 21, 362-369.
62. Wang X., Li W., Williams M., Terada N., Alessi D.R. and Proud C.G. (2001). Regulation of elongation factor 2 kinase by p90(RSK1) and p70 S6 kinase. EMBO J. 20, 4370-4379.
63. Wang L., Rhodes C.J. and Lawrence JC Jr. (2006). Activation of mammalian target of rapamycin (mTOR) by insulin is associated with stimulation of 4EBP1 binding to dimeric mTOR complex 1. J. Biol. Chem. 281, 24293-24303.
64. Wullschleger S., Loewith R. and Hall M.N. (2006). TOR signaling in growth and metabolism. Cell 124, 471-484.
65. Yang W., Zhang Y., Li Y., Wu Z. and Zhu D. (2007). Myostatin induces cyclin D1 degradation to cause cell cycle arrest through a phosphatidylinositol 3-kinase/AKT/GSK-3 beta pathway and is antagonized by insulin-like growth factor 1. J. Biol. Chem. 282, 3799-3808.